FDA Recommends Approval for Game Changing Colon Cancer Blood Test

Aug 6, 2025

Could a simple blood test replace uncomfortable colonoscopies for many people? In July 2024, the FDA approved Shield, a new blood-based screening test developed by Guardant Health. This breakthrough test aims to make colorectal cancer screening easier, less invasive, and more accessible for adults 45 and older—potentially helping to catch cancer earlier and save more lives.

Reported by

Reviewed by

You May Also Like